Pharmacokinetics and bioequivalence of paracetamol in compound tablets of paracetamol,pseudoephedrine and dextromethorphan or paracetamol,pseudoephedrine,diphenhydramine and dextromethorphan in healthy volunteers
Hou Yan-ning
Abstract
Hou Yan-ning
Abstract
AIM:To study the pharmacokinetics and bioequivalence of paracetamol in the compound tablets of paracetamol,pseudoephedrine and dextromethorphan or paracetamol,pseudoephedrine,diphen- hydramine and dextromethorphan in healthy volunteers.METHODS:In a randomized crossover study,20 healthy male volunteers were given orally individual administration of two compound tablets containing paracetamol,pseudoephedrine and dextromethorphan or paracetamol,pseudoephedrine,diphenhydramine and dextromethorphan.Paracetamol in plasma was determined by a HPLC method.RESULTS:As regard to the compound tablets of paracetamol,pseudoephedrine and dextromethorphan,the main pharmacokinetic parameters for paracetamol of test and reference preparations were c_(max) (7.6±s 2.1),(6.6±1.2) mg·L~(-1);t_(max) (0.9±0.6),(1.1±0.6) h;AUC_(0-16) (29±4),(28±5) mg·h·L~(-1),respectively.The relative bioavailability of paracetamol in test preparation was (103±8)%.To the compound tablets of paracetamol,pseudoephedrine, diphenhydramine and dextromethorphan,the main pharmacokinetic parameters for paracetamol of test and reference preparations were c_(max) (6.0±1.0),(6.2±1.2) mg·L~(-1);t_(max) (1.5±0.7),(1.3±0.7) h;AUC_(0-16) (29±6),(29±7) mg·h·L~(-1),respectively.The relative bioavailability of paracetamol was (99±10)%. CONCLUSION:For detection of paracetamol,the test and reference preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To study the pharmacokinetics and bioequivalence of paracetamol in the compound tablets of paracetamol,pseudoephedrine and dextromethorphan or paracetamol,pseudoephedrine,diphen- hydramine and dextromethorphan in healthy volunteers.METHODS:In a randomized crossover study,20 healthy male volunteers were given orally individual administration of two compound tablets containing paracetamol,pseudoephedrine and dextromethorphan or paracetamol,pseudoephedrine,diphenhydramine and dextromethorphan.Paracetamol in plasma was determined by a HPLC method.RESULTS:As regard to the compound tablets of paracetamol,pseudoephedrine and dextromethorphan,the main pharmacokinetic parameters for paracetamol of test and reference preparations were c_(max) (7.6±s 2.1),(6.6±1.2) mg·L~(-1);t_(max) (0.9±0.6),(1.1±0.6) h;AUC_(0-16) (29±4),(28±5) mg·h·L~(-1),respectively.The relative bioavailability of paracetamol in test preparation was (103±8)%.To the compound tablets of paracetamol,pseudoephedrine, diphenhydramine and dextromethorphan,the main pharmacokinetic parameters for paracetamol of test and reference preparations were c_(max) (6.0±1.0),(6.2±1.2) mg·L~(-1);t_(max) (1.5±0.7),(1.3±0.7) h;AUC_(0-16) (29±6),(29±7) mg·h·L~(-1),respectively.The relative bioavailability of paracetamol was (99±10)%. CONCLUSION:For detection of paracetamol,the test and reference preparations are bioequivalent.
Key concepts: Dextromethorphan, Bioequivalence, Pseudoephedrine, Pharmacokinetics, Pharmacology, Bioavailability, Diphenhydramine, Crossover study